Exogenous hyaluronic acid significantly improves the viscoelastic properties of the body’s natural synovial fluid, thereby enhancing shock absorption and lubrication within the joints. By interacting with various surface receptors, the effects of hyaluronic acid can vary based on its concentration and molecular weight, leading to pharmacological and biological pathways that may modulate pain, reduce inflammation, promote tissue regeneration, and stimulate the endogenous synthesis of hyaluronic acid. While the clinical advantages of hyaluronic acid are well recognized, ongoing research aims to develop novel combinations and formulations that prolong its effectiveness and durability. This is achieved by inhibiting degradation and turnover through the action of enzymes and reactive oxygen species, as well as by stabilizing the hyaluronic acid molecule itself. Additionally, hyaluronic acid can be synergistically combined with anti-inflammatory agents, such as corticosteroids, or with other orthobiologic products to enhance therapeutic outcomes. As research continues to expand our knowledge of the body and orthobiologics, innovative formulations and combinations may emerge, further advancing the treatment of arthritic and other musculoskeletal conditions.